[Recalled] VIDAS TOXO IgG Avidity is an automated qualitative test for use on the VIDAS family instruments, for the determination of anti-toxoplasma IgG avidity in human serum or plasma (lithium heparin, sodium citrate, EDTA) using the ELFA
The product on this page is subject to an official recall. We summarise the regulator's findings and the recommended action.
Recall details
| Product | VIDAS TOXO IgG Avidity is an automated qualitative test for use on the VIDAS family instruments, for the determination of anti-toxoplasma IgG avidity in human serum or plasma (lithium heparin, sodium citrate, EDTA) using the ELFA technique (Enzyme Linked Fluorescent Assay). Toxoplasma gondii ser |
|---|---|
| Brand / manufacturer | BioMerieux SA |
| Category | device |
| Issuing authority | FDA_DEVICE |
| Reference | Z-2169-2018 |
| Country of notice | France |
| Risk level | Class II |
| Hazard type | recall |
| Notice date | 23 March 2018 |
| EAN / barcode | 1005621420 |
Why it was recalled
According to the FDA_DEVICE notice, the identified hazard is: A shipment to Guadeloupe suffered a temperature excursions up to 47.8¿C, exceeding the acceptable limits. After detection of the issue, Global Supply Chain QA asked the bioM¿rieux distributor in Guadeloupe to put products in quarantine in July 2017; After several reminders, the distributor informed in November 2017 that products were delivered to customers.
This Class II recall concerns device products distributed in France and was recorded by FDA_DEVICE. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.
What to do if you own this product
Check whether your unit is affected and follow the authority's guidance before further use.
Read the full official notice →
Related recalls from BioMerieux SA
This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.